Conference Coverage
Conference Coverage
Etanercept bests methotrexate for PsA; combo adds little benefit
Conference Coverage
Comorbidities are important in psoriasis care
LAS VEGAS – Cardiovascular comorbidities and psoriatic arthritis top the list of issues to keep an eye on.
Conference Coverage
Over one-third of psoriasis patients have PsA
And more top psoriasis posters from the Las Vegas Dermatology Seminar
Conference Coverage
ACR readies first-ever guidelines on managing reproductive health in rheumatology
CHICAGO – “One of the key messages of the guidelines is that patients really do want to discuss these topics with their rheumatologist,” said Dr....
Conference Coverage
IL inhibitor options move psoriasis treatment forward
Long-term data continue to support the safety and effectiveness of IL-17 and IL-23 inhibitor drugs.
Latest News
Novel oral agent shows unprecedented efficacy in psoriasis
PARIS – Selective tyrosine kinase 2 inhibitor reached a 75% PASI 75 response rate in moderate to severe psoriasis at 12 weeks.
Conference Coverage
Psoriasis pipeline is full of biologics
CHICAGO – “The IL-23 blockers are ideal for patients who want a few injections.”
Conference Coverage
Biosimilar switch accepted by most rheumatic disease patients
LIVERPOOL, ENGLAND – With health systems increasingly favoring biosimilars to biologics, the question is, are patients happy to make the switch?...
Conference Coverage
Adalimumab strikes out for aortic inflammation in psoriasis
ORLANDO – Ustekinumab shows promise, but “we are still not certain.”
Conference Coverage
Checkpoint inhibitors in autoimmune disease: More flares, better cancer outcomes
AMSTERDAM –